Robafen CF Cough and cold is a Oral Solution in the Human Otc Drug category. It is labeled and distributed by Major Pharmaceuticals. The primary component is Guaifenesin; Dextromethorphan Hydrobromide; Phenylephrine Hydrochloride.
| Product ID | 0904-6309_f9196370-2776-452e-bc5d-41bb4f6fcc7f |
| NDC | 0904-6309 |
| Product Type | Human Otc Drug |
| Proprietary Name | Robafen CF Cough and cold |
| Generic Name | Guaifenesin, Dextromethorphan Hydrobromide, And Phenylephrine Hydrochloride |
| Dosage Form | Solution |
| Route of Administration | ORAL |
| Marketing Start Date | 2013-03-05 |
| Marketing End Date | 2019-04-29 |
| Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Labeler Name | Major Pharmaceuticals |
| Substance Name | GUAIFENESIN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE |
| Active Ingredient Strength | 100 mg/5mL; mg/5mL; mg/5mL |
| NDC Exclude Flag | N |
| Marketing Start Date | 2013-03-05 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC monograph final |
| Application Number | part341 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2013-03-05 |
| Marketing End Date | 2019-04-29 |
| Ingredient | Strength |
|---|---|
| GUAIFENESIN | 100 mg/5mL |
| SPL SET ID: | 22bc53c2-e4b4-4821-b80d-8a783d77836a |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0904-6309 | Robafen CF Cough and cold | Guaifenesin, Dextromethorphan Hydrobromide, and Phenylephrine Hydrochloride |
| 53809-250 | DOMETUSS-G | GUAIFENESIN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE |
| 43913-403 | G-BRONCO-D | GUAIFENESIN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE |
| 75834-040 | Nivanex DMX | GUAIFENESIN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE |